CNS vs VRTS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

CNS

59.9
AI Score
VS
VRTS Wins

VRTS

64.5
AI Score

Investment Advisor Scores

CNS

60score
Recommendation
HOLD

VRTS

65score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNS VRTS Winner
Revenue 94.41M 400.90M VRTS
Net Income 29.96M 50.76M VRTS
Net Margin 31.7% 12.7% CNS
Operating Income 36.29M 42.77M VRTS
ROE 9.9% 5.4% CNS
ROA 6.7% 1.1% CNS
Total Assets 450.12M 4.54B VRTS
Free Cash Flow 4.31M 89.63M VRTS

Relative Price Performance (Last 90 Days)

CNS 1M: -5.6% · 3M: -6.9% VRTS 1M: -17.0% · 3M: -12.4%

Current Technical Phase

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 36

RSI (14): 36.2 · Price: $73.12

VRTS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.1%), weak momentum, RSI 35

RSI (14): 35.2 · Price: $132.78

Fundamentals Snapshot

Metric CNS VRTS
Market Cap — —
Forward P/E 18.4 5.5
Trailing P/E 22.4 7.5
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.5% 0.4%
Operating Margin 0.3% 0.1%
EPS 3.26 17.54
Dividend Yield 0.04% 0.07%

Frequently Asked Questions

Based on our detailed analysis, VRTS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.